Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine
Authors:
- Anju DhawanADAnju Dhawan
- Ravindra RaoRRRavindra Rao
- Ashwani Kumar MishraAMAshwani Kumar Mishra
- Raka JainRJRaka Jain
- Sanjeev SinhaSSSanjeev Sinha
- 1 March 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 14 (2) , 132-138
Abstract
Objectives: To assess the rates of sleep disturbances in male patients with opioid dependence maintained on buprenorphine and to assess the factors associated with sleep disturbances in this population. Methods: Observational, cross-sectional study. Male patients with opioid dependence aged 18 years and older, and started on buprenorphine at least 6 months before were screened. Those with history of comorbid psychiatric illnesses (except sleep disorders), on any other substance in high-risk category (based on WHO-Alcohol Smoking Substance Involvement Screening Test (ASSIST)), or on any other psychotropic medications (in addition to OAT with buprenorphine) were excluded. Sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI), Sleep-50, and Epworth Sleepiness Scale (ESS). Each participant was interviewed in a single session lasting 60 minutes. Results: One hundred six participants were included. Their mean age was 41.1 (SD 14.3) years. The participants had been on OAT with buprenorphine for a median duration of 60 months (IQR 17–120), with excellent adherence rate in past 1 month. The mean current dose of buprenorphine was 10.2 (SD 3.8) mg per day. The mean subjective total sleep time was 403.5 minutes (SD 94.8) and the median sleep latency was 35 minutes (IQR 18.8–62.5). The mean PSQI score was 6.6 (SD 3.4). Nearly 63% (n = 67) participants had PSQI scores more than 5 (PSQI > 5) suggesting sleep problems. Sociodemographic, substance use, and treatment variables were compared between participants who scored more than 5 and those who scored less than 5 on PSQI. No significant difference was found between the 2 groups. Conclusions: Substantial proportion of male patients with opioid dependence maintained on buprenorphine have sleep problems. The sleep problems in buprenorphine-maintained patients seem to be independent of substance use and treatment-related attributes.Keywords
This publication has 43 references indexed in Scilit:
- Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 DiabetesDiabetes & Metabolism Journal, 2012
- No Change of Sleep After 6 and 12 Months of Methadone Maintenance TreatmentJournal of Addiction Medicine, 2011
- Sleep Profile in Patients With Chronic Opioid AbuseAddictive Disorders & Their Treatment, 2011
- Assessing sleep in opioid dependence: A comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patientsDrug and Alcohol Dependence, 2011
- Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substancesMedical Hypotheses, 2010
- Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone doseEuropean Neuropsychopharmacology, 2009
- Home Polysomnography in Methadone Maintenance Patients with Subjective Sleep ComplaintsThe American Journal of Drug and Alcohol Abuse, 2009
- Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in IsraelDrug and Alcohol Dependence, 2006
- Sleep‐disordered breathing in stable methadone programme patients: a pilot studyAddiction, 2001
- The Assessment of Cancer Pain in North IndiaJournal of Pain and Symptom Management, 1999